# Medical Oncology * **Definition:** A branch of medicine that specializes in the diagnosis and treatment of cancer. * **Taxonomy:** Specialties / Medical Oncology ## News * Selected news on the topic of **Medical Oncology**, for healthcare technology leaders * 10.9K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/8/2025 | [**Why screen for iron deficiency? It's common, consequential and curable - Medical Xpress**](https://medicalxpress.com/news/2025-05-screen-iron-deficiency-common-consequential.html) | [[MedicalXpress]] | | 3/24/2025 | [**Tenet Healthcare hiring Multi Skilled Tech Medical Surgical Full Time Days in El Paso, TX**](https://www.linkedin.com/jobs/view/multi-skilled-tech-medical-surgical-full-time-days-at-tenet-healthcare-4192432235) | [[Linkedin]] | | 12/26/2024 | [**Cosmos Health Appoints Dimitrios Trafalis as Head of Oncology - FirstWord Pharma**](https://firstwordpharma.com/story/5923956) | [[FirstWord PHARMA]] | | 12/17/2024 | [**Caris Life Sciences Appoints Dr. James Hamrick as Chairman of the Caris Precision ...**](https://www.prnewswire.com/news-releases/caris-life-sciences-appoints-dr-james-hamrick-as-chairman-of-the-caris-precision-oncology-alliance-302332807.html) | [[PR Newswire]] | | 12/12/2024 | [**Health IT Business News - December 12, 2024**](https://www.healthitanswers.net/health-it-business-news-december-12-2024/) | [[Health IT Answers]] | | 11/15/2024 | [**Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241115785002/en/Whole-Genome-and-Exome-Sequencing-Markets-2033---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/14/2024 | [**Community Oncology Partners Names CBRE Health as Real Estate Partner for Nationwide Expansion of Community-Based Medical Oncology Practices**](https://www.prweb.com/releases/community-oncology-partners-names-cbre-health-as-real-estate-partner-for-nationwide-expansion-of-community-based-medical-oncology-practices-302306451.html) | [[PRWeb]] | | 11/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for November 2024**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-november-2024-302293808.html) | [[PRWeb]] | | 11/1/2024 | [**Ferrum Health Raises $16M in Series A Funding to Unlock AI Adoption in Healthcare**](https://www.healthcareittoday.com/2024/11/01/ferrum-health-raises-16m-in-series-a-funding-to-unlock-ai-adoption-in-healthcare/) | [[Healthcare IT Today]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals) | [[Business Wire]] | | 10/29/2024 | [**Asia-Pacific Digital Diagnostics Market Analysis and Forecast, 2023-2024 & 2033: Synergetic Partnership Opportunities with Hospitals and Diagnostic Centers Fuel Opportunities - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241029232642/en/Asia-Pacific-Digital-Diagnostics-Market-Analysis-and-Forecast-2023-2024-2033-Synergetic-Partnership-Opportunities-with-Hospitals-and-Diagnostic-Centers-Fuel-Opportunities---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics' Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals**](http://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/22/2024 | [**HLTH: Avandra Launches World's Largest Federated Network for Medical Imaging and Clinical Data**](https://hitconsultant.net/2024/10/22/avandra-launches-worlds-largest-federated-network-for-medical-imaging-and-clinical-data/) | [[HIT Consultant]] | | 10/16/2024 | [**FDA strengthens AI regulation to ensure patient safety and innovation in healthcare**](https://www.news-medical.net/news/20241016/FDA-strengthens-AI-regulation-to-ensure-patient-safety-and-innovation-in-healthcare.aspx) | [[News Medical Net]] | | 10/9/2024 | [**Look Who's Talking at HLTH - MedCity News**](https://medcitynews.com/2024/10/look-whos-talking-at-hlth/) | [[MedCity News]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/4/2024 | [**Viz.ai and ALCMI Partner to Unite AI and Lung Cancer Research Communities**](https://www.businesswire.com/news/siliconvalley/20240904868268/en) | [[Business Wire]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 9/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for September 2024**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-september-2024-302235364.html) | [[PRWeb]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/12/2024 | [**Quantum Health Appoints Dr. Stanley Crittenden as New Chief Medical Officer**](http://www.businesswire.com/news/home/20240812304065/en/Quantum-Health-Appoints-Dr.-Stanley-Crittenden-as-New-Chief-Medical-Officer/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 6/25/2024 | [**BioAI and Genomic Testing Cooperative Announce Strategic Collaboration to Provide AI-Powered Digital Pathology Solutions for Clinical Research and Diagnostic Applications**](https://www.prnewswire.com/news-releases/bioai-and-genomic-testing-cooperative-announce-strategic-collaboration-to-provide-ai-powered-digital-pathology-solutions-for-clinical-research-and-diagnostic-applications-302181005.html) | [[PR Newswire]] | | 6/21/2024 | [**AI outperforms peers in medical oncology quiz, yet some mistakes could be harmful**](https://www.news-medical.net/news/20240621/AI-outperforms-peers-in-medical-oncology-quiz-yet-some-mistakes-could-be-harmful.aspx) | [[News Medical Net]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **MEDSIR**: An independent clinical research organization in oncology, participating in international symposiums to advance cancer treatment. - **Massive Bio**: Provides AI-driven patient matching technology to improve access to clinical trials in oncology. - **Cambium Oncology**: A biotech firm developing next-generation immuno-oncology therapeutics, partnered with Orient Euro Pharma for clinical development. - **Myriad Genetics**: A company innovating in oncology and hereditary cancer testing, focusing on digital capabilities and strategic partnerships. - **Community Oncology Partners (COP)**: A healthcare organization focused on enhancing access to cancer care through the establishment of localized oncology practices. - **NeoGenomics**: A laboratory services company specializing in cancer genetics and diagnostics, collaborating with ConcertAI on hematological disease analytics. - **Foundation Medicine**: Focuses on next-generation sequencing and genomic profiling to empower personalized treatment options. - **N-Power Medicine**: A clinical research and drug development platform focused on enhancing clinical trial participation and accelerating oncology drug development. - **Integrated Oncology Network (ION)**: A network of oncology practices that provides a range of oncology-related services and is being integrated into Cardinal Health's Navista platform. - **CBRE**: A consulting healthcare practice group that partners with COP to facilitate the development of medical oncology sites. - **ConcertAI**: Offers predictive and generative AI solutions in oncology, enhancing clinical decision-making and real-world data utilization. - **Reimagine Care**: A healthcare technology company expanding its symptom-management program to support surgical oncology patients. - **J INTS BIO**: A company developing personalized lung cancer therapies through AI and multi-omics technology. - **SOPHiA GENETICS**: A company collaborating with AstraZeneca to utilize machine learning models for identifying patient subgroups in lung cancer treatment. - **Byondis B.V.**: A clinical-stage biopharmaceutical company focused on targeted cancer treatments, recently appointing Dr. Louis Denis as Chief Medical Officer. - **CEL-SCI Corporation**: A biotechnology company presenting data on its Multikine immunotherapy for head and neck cancer. - **Cardinal Health**: A healthcare services and products company that has announced the acquisition of Integrated Oncology Network to enhance its oncology services. - **OneCell Diagnostics**: A genomics-based precision oncology company focused on making precision oncology more accessible through advanced cancer diagnostic testing. ### Partnerships and Collaborations - **MEDSIR and Oncoclínicas**: Collaboration to enhance access to innovative cancer treatments through international clinical research. - **Lowcountry Oncology Associates and OneOncology**: Partnership to improve cancer service delivery in Charleston, South Carolina, expanding services across new clinics. - **Azra AI and MultiCare Health System**: Implementing a comprehensive oncology platform to enhance cancer care delivery. - **N-Power Medicine and Merck**: A partnership to facilitate access to clinical trials for oncologists and patients, improving enrollment processes. - **City of Hope and SWOG Cancer Research Network**: Collaboration to investigate the effects of CBM588 on advanced cancer patients. - **Flatiron Health and global oncology developers**: Collaborative efforts to enhance research rigor in oncology. - **Myriad Genetics and Flatiron Health**: Collaboration to integrate MyRisk hereditary cancer testing into the OncoEMR platform for streamlined workflows. - **TMC Japan BioBridge**: A collaboration between Texas Medical Center and Japanese institutions to enhance cancer treatment through shared expertise and market access. - **ICPO Foundation and NuMeRI**: A collaboration to establish a theranostics center in South Africa to enhance cancer therapy access. - **Bicara Therapeutics and various industry leaders**: Partnerships to advance bifunctional therapies for solid tumors. - **careMESH and Epic**: Integration of the NAVIGATE platform into Epic's EHR systems to improve patient care coordination in oncology. - **Owkin and DACH Medical Institutions**: Collaborations to enhance treatment outcomes for various cancers using AI. - **Massive Bio and Foundation Medicine**: Strategic collaboration to improve patient access to clinical trials using AI-driven patient matching. - **SOPHiA GENETICS and AstraZeneca**: Collaboration to identify subgroups of lung cancer patients who could benefit from specific treatments using machine learning. - **OneCell Diagnostics and Harvard Medical School/Stanford University**: Strategic partnerships to support the scalability and effectiveness of OneCell's technology in precision oncology. - **COP and CBRE**: A strategic partnership aimed at developing state-of-the-art oncology facilities to improve access to cancer care in underserved communities. - **Cofactor Genomics and Dr. Howard McLeod**: Dr. McLeod's appointment to the advisory board aims to implement precision medicine solutions in healthcare systems. - **Flatiron Health and Lifebit Biotech**: Collaboration to enhance cancer care in Japan through secure access to real-world oncology data. - **Cambium Oncology and Orient Euro Pharma**: A strategic partnership to expedite the clinical development of Cambium's lead therapeutic candidate, ANT308. - **J INTS BIO and Yonsei University**: An AI-driven collaboration aimed at developing personalized lung cancer therapies. ### Innovations, Trends, and Initiatives - **Theranostics**: An emerging field combining diagnostic imaging and therapeutic delivery for precise, patient-centric cancer care. - **Artificial Intelligence in Oncology**: AI is being utilized to enhance personalized medicine approaches, as seen in studies presented at ESMO conferences. - **Microbiome Diagnostics**: Growing interest in microbiome diagnostics for early disease detection and monitoring, particularly in oncology. - **New Treatment Combinations**: Innovative combinations of immunotherapy and chemotherapy are showing promising results in treating various cancers, including metastatic non-small cell lung cancer. - **AI in Oncology**: The use of AI technologies is driving advancements in precision medicine, particularly in analyzing genomic data for personalized treatment plans. - **Microbiome Research**: Studies indicating the influence of gut microorganisms on cancer treatment outcomes, leading to new therapeutic strategies. - **Precision Medicine Software Market Growth**: The market is projected to grow significantly, driven by advancements in AI and increasing demand for personalized cancer treatments. - **Expansion of Symptom-Management Programs**: Reimagine Care's initiative to support surgical oncology patients highlights the growing focus on post-operative care. - **CAR T-cell Therapy**: Innovative treatment for advanced cancers, including multiple myeloma, demonstrating improved survival rates. - **CRISPR Technology in Oncology**: Advancements in gene editing technologies are enhancing personalized medicine approaches in cancer treatment. - **Next Generation Cancer Diagnostics (NGCD)**: A rapidly growing market utilizing technologies like liquid biopsy and genomics to enhance diagnostic accuracy and targeted therapies. - **Real-World Evidence Utilization**: Leveraging real-world data to inform clinical practices and improve treatment strategies in oncology. - **Hyper-Personalized Medicine**: Tailoring treatments based on genetic, environmental, and lifestyle factors, driven by advancements in genomics and data analytics. - **Theranostics Innovations**: GE HealthCare is introducing new technologies that combine therapeutic and diagnostic capabilities for personalized cancer treatment. - **Project EVOLVE**: An initiative utilizing AI to analyze patient records for better management of adverse events in cancer treatment. - **AI-Powered Oncology Workflow Automation**: Azra AI's solutions aim to improve healthcare provider satisfaction and transform oncology care. ### Challenges and Concerns - **Clinical Trial Participation**: Only 5% of cancer patients currently enroll in clinical trials, highlighting a need for increased oncologist participation. - **Regulatory and Policy Changes**: Potential shifts in healthcare policies could impact community oncology practices and patient access to care. - **Recruitment in Clinical Trials**: Challenges in optimizing recruitment processes for clinical trials, particularly in oncology research. - **Shortage of Oncology Professionals**: A significant lack of trained oncologists and nurses in regions like SAARC, impacting cancer care delivery. - **High Technology Costs**: The high costs associated with advanced oncology technologies pose a barrier to widespread adoption. - **Technology Adoption in Community Oncology**: Limited resources and expertise hinder the adoption of new healthcare technologies, necessitating careful assessment of needs and technology selection. - **Burnout Among Oncologists**: A significant percentage of oncologists are experiencing burnout, with surveys indicating that 57% are affected, highlighting the need for support systems. - **Regulatory Hurdles**: Regulatory challenges can impede the development and implementation of innovative oncology solutions. - **Patient-Centric Treatment Development**: The necessity of incorporating feedback from patients and healthcare systems into the development of new cancer treatments. - **Access to Care**: Despite advancements, there remains a challenge in providing equitable access to high-quality cancer care, particularly in underserved areas. - **Health Equity**: Persistent racial and ethnic disparities in cancer care, emphasizing the need for equitable treatment opportunities. - **Access to Clinical Trials**: There is an urgent need for effective solutions to facilitate patient identification for clinical trials, particularly in oncology. - **Healthcare Workforce Crisis**: The global health workforce crisis is projected to result in an 18 million staff shortfall by 2030, impacting oncology care delivery. - **Data Security and Compliance**: Ensuring compliance with regulations like HIPAA while integrating new technologies remains a significant concern for oncology practices. - **Cost and Accessibility**: High costs and systemic toxicity of advanced therapies like CAR T-cell treatments pose challenges for patient access. - **Fragmented Technology Systems**: Community oncology practices often face technology overload, leading to a fragmented system of disconnected solutions that complicate operations. - **Reimbursement Cuts**: Concerns regarding potential reimbursement cuts for oncology providers due to drug price negotiations under the Inflation Reduction Act. - **Racial and Socioeconomic Disparities**: Significant disparities in access to quality cancer care persist, highlighting the need for addressing social determinants of health. - **Integration of New Technologies**: The integration of AI and digital tools in oncology practices raises concerns regarding data security and the need for clinician training. ## Related Topics [[Oncology]]; [[Precision Oncology]]; [[Pediatric Oncology]]; [[Surgical Oncology]]